血栓切除术后高信号再灌注标志物与眼部钆渗漏的临床意义:ETIS回顾性研究
基于法国ETIS注册研究(2010-2021)229例机械取栓患者,术后4-48小时行增强FLAIR成像。HARM见于48.9%、GLOS见于41.9%的患者;HARM独立关联早期神经功能恶化与梗死进展,GLOS则无独立关联。
要点
- HARM与取栓后早期神经功能恶化和梗死进展独立相关。
- GLOS虽常见,但与临床及影像结局无独立关联。
- 单次再通是HARM的独立预测因素,或反映血脑屏障损伤。
核心结论
- 取栓后HARM是早期血脑屏障破坏的影像标志物,独立关联早期神经功能恶化与梗死进展。
- GLOS发生率高,但未显示与临床或影像结局的独立关联。
研究设计与样本
- 法国ETIS注册研究(2010-2021)的回顾性分析,纳入凡尔赛与Foch医院连续收治的取栓患者。
- 共229例,平均年龄69.7±14.9岁,女性占52.0%,均在钆剂注射后4-48小时行pcFLAIR成像。
- 采用多变量logistic回归识别HARM与GLOS的独立预测因素并评估其与结局的关联。
主要发现
- HARM见于48.9%的患者,GLOS见于41.9%,任一标志物阳性者占60.3%。
- 同时存在两种标志物者占29.3%,孤立HARM占19.7%,孤立GLOS占11.4%。
- HARM独立关联早期神经功能恶化(aOR 3.45;95% CI 1.33-8.95)与梗死进展(aOR 2.46;95% CI 1.22-4.95)。
- HARM与出血转化及3个月功能结局无独立关联;GLOS与临床或影像结局均无独立关联。
- 年龄较大、肌酐较高及两次FLAIR间隔较短是HARM与GLOS的共同预测因素,单次再通仅为HARM的独立预测因素。
临床怎么用
- 取栓后pcFLAIR出现HARM可提示早期血脑屏障破坏,有助于识别易发生早期神经功能恶化或梗死进展的患者。
- GLOS不宜单独作为预后判断依据。
局限性
- 为回顾性研究,仅纳入两家医院的患者,结论需前瞻性研究验证。
- 作者指出需开展早期及系列影像的前瞻性研究以明确HARM的预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Despite successful recanalization after mechanical thrombectomy for acute ischemic stroke, a substantial proportion of patients experience early neurologic deterioration or infarct progression. Early blood-brain barrier disruption, visualized on post-contrast fluid-attenuated inversion recovery (pcFLAIR) imaging as hyperintense acute reperfusion marker (HARM) or gadolinium leakage in ocular structures (GLOS), has been proposed as a marker of reperfusion injury, but its determinants and prognostic significance in thrombectomy cohorts remain uncertain. We aimed to evaluate whether HARM and GLOS are associated with poor clinical outcomes after mechanical thrombectomy. Secondary objectives included their association with poor radiologic outcomes and the identification of baseline and procedural predictors. METHODS: We retrospectively analyzed data from the French Endovascular Treatment in Ischemic Stroke (ETIS) registry (2010-2021), including consecutive patients admitted to Versailles and Foch Hospital. All patients underwent mechanical thrombectomy at Foch Hospital and pcFLAIR imaging within 4-48 hours postgadolinium administration. Independent predictors of HARM and GLOS were identified through multivariable logistic regression, and their associations with early neurologic deterioration, poor 3-month functional outcome, infarct growth, and hemorrhagic transformation (HT) outcomes were evaluated. RESULTS: Among 229 patients (mean age 69.7 ± 14.9 years, 52.0% female), HARM was observed in 48.9% and GLOS in 41.9%. Overall, 60.3% of patients had either HARM or GLOS, including 29.3% with both markers, 19.7% with isolated HARM, and 11.4% with isolated GLOS. HARM was independently associated with early neurologic deterioration (adjusted odds ratio [aOR] 3.45; 95% CI 1.33-8.95) and infarct growth (aOR 2.46; 95% CI 1.22-4.95), but not with HT or 3-month functional outcome. GLOS was not independently associated with clinical or radiologic outcomes. Older age, higher creatinine, and a shorter interval between the first and second FLAIR were common predictors of both HARM and GLOS, whereas single-pass recanalization was an independent predictor of HARM only. DISCUSSION: In this large thrombectomy cohort, HARM was independently associated with early neurologic deterioration and infarct progression after thrombectomy, supporting its role as an imaging marker of early blood-brain barrier disruption. GLOS, although frequent, was not independently associated with clinical or radiologic outcomes. Prospective studies with early and serial imaging are required to clarify the prognostic relevance of HARM. TRIAL REGISTRATION INFORMATION: NCT03776877 (ETIS registry).
引用
- Bousfiha C, Vinacci G, Gratieux J, et al. Clinical Significance of the Hyperintense Reperfusion Marker and Ocular Gadolinium Leakage After Thrombectomy: A Retrospective ETIS Study. Neurology. 2026. PMID: 42579823. doi:10.1212/WNL.0000000000218412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。